Qiao Liu Selected Research

phillyrin

7/2022

Phillyrin attenuates norepinephrine-induced cardiac hypertrophy and inflammatory response by suppressing p38/ERK1/2 MAPK and AKT/NF-kappaB pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiao Liu Research Topics

Disease

37	Neoplasms (Cancer) 04/2022 - 02/2006
13	Infections 02/2022 - 12/2011
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2019
10	Tuberculosis (Tuberculoses) 12/2021 - 12/2011
8	Inflammation (Inflammations) 06/2022 - 05/2012
6	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2006
6	Breast Neoplasms (Breast Cancer) 08/2019 - 11/2012
5	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2015
5	Hypoxia (Hypoxemia) 12/2020 - 09/2011
4	COVID-19 03/2022 - 01/2020
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2018 - 12/2013
3	Asthma (Bronchial Asthma) 04/2022 - 01/2018
3	Leukemia 01/2022 - 10/2017
3	Carcinogenesis 12/2021 - 12/2012
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2017
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 05/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2010
3	Esophageal Neoplasms (Esophageal Cancer) 01/2011 - 01/2007
2	Disease Resistance 06/2022 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 08/2021
2	Carcinoma (Carcinomatosis) 12/2021 - 02/2006
2	Melanoma (Melanoma, Malignant) 12/2021 - 01/2021
2	Parkinson Disease (Parkinson's Disease) 08/2021 - 03/2021
2	Chronic Renal Insufficiency 01/2021 - 01/2021
2	Hypersensitivity (Allergy) 08/2020 - 01/2019
2	Genomic Instability 01/2020 - 04/2011
2	Wounds and Injuries (Trauma) 11/2019 - 03/2017
2	Disease Progression 01/2019 - 01/2009
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 02/2015
2	Lung Neoplasms (Lung Cancer) 10/2018 - 02/2006
2	Triple Negative Breast Neoplasms 03/2016 - 07/2015
2	Hemorrhage 12/2015 - 01/2011
2	Syphilis 09/2012 - 04/2012
1	Chronic Hepatitis B 12/2022
1	Reinfection 11/2022
1	Malnutrition (Nutritional Deficiencies) 08/2022
1	Cardiomegaly (Heart Hypertrophy) 07/2022

Drug/Important Bio-Agent (IBA)

13	Pharmaceutical PreparationsIBA 04/2022 - 12/2011
9	Proteins (Proteins, Gene)FDA Link 04/2022 - 02/2006
8	AntioxidantsIBA 07/2022 - 01/2016
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2011
7	BerberineIBA 01/2019 - 03/2009
6	EnzymesIBA 01/2022 - 04/2012
4	VaccinesIBA 02/2022 - 01/2007
4	MicroRNAs (MicroRNA)IBA 12/2021 - 10/2018
4	NivolumabIBA 01/2021 - 02/2020
4	pembrolizumabIBA 01/2021 - 12/2019
4	AlkaloidsIBA 10/2017 - 03/2009
3	p38 Mitogen-Activated Protein KinasesIBA 07/2022 - 10/2013
3	PlatinumIBA 01/2022 - 01/2021
3	AntigensIBA 12/2021 - 02/2006
3	Rifampin (Rifampicin)FDA LinkGeneric 12/2021 - 01/2015
3	Tuberculin (PPD)IBA 12/2021 - 11/2017
3	ResveratrolIBA 02/2021 - 11/2010
3	IpilimumabIBA 01/2021 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2020
3	atezolizumabIBA 01/2021 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 11/2020 - 02/2015
2	NF-kappa B (NF-kB)IBA 07/2022 - 10/2017
2	Messenger RNA (mRNA)IBA 06/2022 - 12/2013
2	CarbohydratesIBA 06/2022 - 12/2021
2	COVID-19 VaccinesIBA 03/2022 - 11/2021
2	Superoxides (Superoxide)IBA 01/2022 - 01/2020
2	Bevacizumab (Avastin)FDA Link 01/2022 - 01/2022
2	Therapeutic UsesIBA 01/2022 - 10/2017
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 07/2020
2	Biosimilar PharmaceuticalsIBA 01/2022 - 01/2022
2	Docetaxel (Taxotere)FDA Link 01/2021 - 02/2020
2	Biological ProductsIBA 01/2021 - 07/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2016
2	interleukin-21 (interleukin 21)IBA 01/2021 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 04/2020
2	LipidsIBA 01/2021 - 04/2020
2	Immune Checkpoint InhibitorsIBA 01/2021 - 02/2020
2	CholesterolIBA 01/2021 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 04/2020
2	CytokinesIBA 10/2020 - 01/2017
2	Lactic Acid (Lactate)FDA LinkGeneric 07/2020 - 04/2020
2	Liver GlycogenIBA 07/2020 - 04/2020
2	Caspase 3 (Caspase-3)IBA 07/2020 - 01/2007
2	Insulin (Novolin)FDA Link 04/2020 - 11/2017
2	Hormones (Hormone)IBA 08/2019 - 01/2017
2	Moclobemide (Arima)IBA 01/2019 - 01/2019
2	ArtesunateIBA 01/2019 - 01/2015
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018 - 10/2017
2	Estrogens (Estrogen)FDA Link 01/2017 - 03/2016
2	Oncogene Proteins (Oncogene Protein)IBA 01/2007 - 02/2006
1	Receptor for Advanced Glycation End ProductsIBA 12/2022
1	Particulate MatterIBA 08/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2022
1	Atrial Natriuretic Factor (ANF)IBA 07/2022

Therapy/Procedure

18	Therapeutics 04/2022 - 02/2006
11	Drug Therapy (Chemotherapy) 01/2022 - 01/2011
6	Immunotherapy 01/2022 - 02/2006
3	Aftercare (After-Treatment) 11/2022 - 01/2021
2	Precision Medicine 04/2022 - 01/2021
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 12/2016